Related Experiment Video
Updated: Jul 9, 2026
High-throughput Detection Method for Influenza Virus
Published on: February 4, 2012
Rapid detection of influenza A virus in clinical samples using an ion channel switch biosensor
1Infectious Diseases Laboratories, Institute of Medical & Veterinary Science, Adelaide, SA, Australia.
Insights
A novel ion channel switch biosensor (ICSB) enables rapid, point-of-care detection of influenza A virus in respiratory samples within 10 minutes. This biosensor offers a faster alternative to traditional methods for influenza A diagnosis.
Area of Science:
- Biomedical Engineering
- Infectious Disease Diagnostics
- Biosensor Technology
Background:
- Influenza A virus poses a significant public health threat, necessitating rapid and accurate diagnostic tools.
- Current diagnostic methods like virus culture and rapid antigen tests have limitations in speed and objectivity.
- Point-of-care testing (POCT) is crucial for timely clinical decisions and outbreak management.
Purpose of the Study:
- To fabricate and evaluate the performance of an ion channel switch biosensor (ICSB) for the detection of influenza A virus.
- To compare the ICSB's diagnostic capabilities with established methods, including virus culture and rapid immunochromatographic tests.
- To assess the ICSB's potential for rapid, point-of-care diagnosis of influenza A in various respiratory specimens.
Main Methods:
- Fabrication of the ion channel switch biosensor (ICSB) utilizing specific antibodies for influenza A detection.
- Testing the ICSB with different types of respiratory specimens.
- Comparative analysis of ICSB results against virus culture (gold standard) and a rapid immunochromatographic test.
- Evaluation of the time required for specimen processing and result readout.
Main Results:
- The ICSB demonstrated successful rapid detection of influenza A virus in respiratory specimens.
- Objective results were obtained within 10 minutes of specimen inoculation.
- The ICSB required no chemical or other pre-treatments, simplifying the testing process.
- The biosensor showed potential for identifying specific influenza A subtypes.
Conclusions:
- The ion channel switch biosensor (ICSB) is a promising technology for rapid, point-of-care detection of influenza A.
- The ICSB offers a significant advantage in speed and ease of use compared to conventional diagnostic methods.
- Further development of the ICSB could enhance influenza A surveillance and patient management strategies.
Abstract:
This report describes the fabrication and successful use of the ion channel switch biosensor (ICSB) for rapid point-of-care detection of influenza A in different types of respiratory specimens. Virus culture -- regarded as the "gold standard" -- and an immunochromatographic rapid point-of-care test for influenza A virus were compared with the biosensor. The ICSB rapid test provided an objective readout within 10 min of specimen inoculation into the ICSB chamber wells, without the need for chemical or other pretreatments. Construction of the ICSB with specific antibodies also enables rapid detection and identification of appropriate influenza A subtypes.
